查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659392

全球尿道結石管理設備市場

Urolithiasis Management Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球尿道結石管理設備市場規模將達 28 億美元

2024 年全球尿道結石管理設備市場規模估計為 20 億美元，預計到 2030 年將達到 28 億美元，2024-2030 年分析期間的複合年成長率為 5.5%。體外震波碎石術 (ESWL) 治療是報告中分析的一個細分領域，預計其複合年成長率為 5.3%，到分析期結束時將達到 11 億美元。在分析期內，體外碎石部分預計以 5.8% 的複合年成長率成長。

美國市場規模估計為 5.287 億美元，而中國市場預計以 8.3% 的複合年成長率成長

預計 2024 年美國尿道結石管理設備市場價值將達到 5.287 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 6.289 億美元，2024-2030 年分析期間的複合年成長率為 8.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.3% 和 4.4%。在歐洲，德國的複合年成長率預計為 4.0%。

全球尿道結石管理設備市場 - 主要趨勢與促進因素摘要

什麼是尿道結石管理裝置？

尿道結石管理設備是一種用於診斷、管理和治療尿道結石（包括腎臟、輸尿管、膀胱和尿道）中形成結石的疾病的醫療設備。尿道結石，俗稱腎結石，如果不及時治療，會導致劇烈疼痛、閉尿症和腎臟損傷。這些設備包括多種技術，包括體外震波碎石術 (ESWL)、輸尿管鏡、腎鏡、雷射碎石術和支架，旨在分解、去除或促進腎結石通過泌尿道。這些設備可進行非侵入性治療和微創治療，進而改善患者的治療效果並縮短恢復時間。

尿道結石管理設備的重要性在於它們能夠解決影響全球數百萬人的常見健康問題。飲食習慣、脫水、肥胖和某些醫療狀況等因素都會造成腎結石的形成，因此有效的管理對於維持腎臟健康至關重要。早期診斷和及時治療對於預防感染疾病、腎衰竭和復發性結石等併發症至關重要。尿道結石管理設備為醫療保健專業人員提供了根據結石的大小、成分和位置制定治療計劃的工具，提供了以患者為中心的腎結石管理方法。隨著全球尿道結石的發病率持續上升，這些設備在確保有效、安全和高效的治療方面發揮著至關重要的作用。

科技進步如何影響尿道結石管理設備市場？

技術進步顯著提高了尿道結石管理設備的準確性、有效性和安全性，推動了腎結石治療的創新。最顯著的進展之一是體外震波碎石術 (ESWL) 的改進。這是一種非侵入性技術，利用聚焦衝擊波將腎結石分解成可以自然通過的小碎片。現代 ESWL 機器提供即時成像、改進的結石定位和患者定位功能，從而提高成功率、縮短治療時間並增加患者的舒適度。此外，電磁和壓電碎石機的進步提高了 ESWL 設備的精度和能量傳輸，提高了結石破碎的效率。

微創手術在輸尿管鏡和腎臟鏡的設計、靈活性和影像處理能力方面取得了巨大進展。數位輸尿管鏡的發展提供了高清影像，提高了尿道結石的檢測、定位和去除能力。微型軟性輸尿管鏡可以接觸到難以觸及的結石，同時最大限度地減少對周圍組織的創傷並縮短恢復時間。雷射碎石術也隨著創新而發展，例如使用提供高脈衝率、可調脈衝寬度和雙波長技術的鈥雷射系統。這些進步使得結石破碎更加有效，特別是對於較硬或較大的結石，並且可以更好地控制手術過程，並提高安全性。

另一個重要進展是使用機器人輔助手術器械來治療複雜的腎結石切除病例。機器人技術提供了更高的精確度、控制力和靈活性，以改善經皮腎結石 (PCNL) 和其他侵入性手術的結果。此外，改進的支架設計，如藥物釋放型和生物分解性支架，可以幫助術後護理管理並減少輸尿管阻塞和感染疾病等併發症。這些創新不僅擴展了尿道結石管理設備的功能，而且符合更廣泛的趨勢，即微創、對病人友善的治療方法，可減少住院時間和醫療費用。

尿道結石管理設備在醫療保健領域有哪些新興應用？

由於腎結石發病率的不斷上升和治療方法的進步，尿道結石管理設備被廣泛應用於各種醫療保健領域。它們廣泛用於醫院和專科泌尿系統中心的診斷和治療目的，支持 ESWL、輸尿管鏡檢查和經皮腎鏡碎石術 (PCNL) 等程序。泌尿系統依靠先進的成像和雷射系統來確保準確定位、有效破碎和徹底清除結石，改善患者的治療效果並降低復發率。這些設備對於門診手術中心也很重要，因為門診手術中心通常會採用微創手術來治療小結石，以便患者當天出院並更快地康復。

在急救環境中，掌上超音波診斷設備和可攜式影像工具對於快速診斷和評估急性尿道結石例至關重要，可以快速決策適當的治療方法。遠端醫療平台還整合了遠距諮詢和診斷功能，用於初步評估和後續護理，支援更廣泛地獲得尿道結石管理。在初級保健和診所，超音波和先進的尿液分析套件等非侵入性診斷工具可用於早期發現結石形成，以便及時轉診給專科醫生並減少緊急干預的需要。此外，在居家醫療環境中，穿戴式感測器和數位健康應用程式被用於監測水分、飲食攝取量和潛在的結石症狀，幫助患者主動管理尿道結石。隨著醫療保健變得更加分散和以患者為中心，尿道結石管理設備的應用範圍正在不斷擴大，反映了它們在不同護理環境中滿足不同醫療保健需求的多功能性。

推動尿道結石管理設備市場成長的因素是什麼？

尿道結石管理設備市場的成長受到多種因素的推動，例如腎結石盛行率的上升、微創治療的採用率的提高以及診斷和治療技術的進步。其中一個主要成長要素是全球尿道結石例的增加，這是由生活方式因素造成的，例如缺水、高鈉飲食、肥胖以及糖尿病和高血壓等代謝疾病。隨著腎結石發病率的增加，對有效、及時的管理解決方案的需求急劇上升，使得尿道結石管理設備成為醫療保健提供者必不可少的工具。由於患者和醫療保健提供者更喜歡恢復更快、疼痛更少、併發症率更低的治療，人們對體外震波碎石術、輸尿管鏡檢查和雷射碎石術等微創手術的認知不斷提高，推動了這些設備的進一步應用。

成像和雷射技術的進步也在市場成長中發揮關鍵作用。高清數位輸尿管鏡、先進的碎石機和人工智慧診斷工具的發展提高了腎結石治療的準確性、安全性和效率，從而改善了患者的治療效果。此外，人工智慧和機器學習在成像和診斷領域的整合正在增強結石的檢測、表徵和治療計劃，使尿道結石管理更加精準和個性化。政府措施和醫療政策促進了更好的泌尿系統治療、增加了醫療保健的機會以及開展了有關預防和管理腎結石的宣傳活動，進一步支持了市場的成長。

門診手術中心和門診診所的增加也促進了尿道結石管理設備市場的成長。這些設施提供經濟高效的護理，並增加了患者接受微創手術的機會。隨著遠距遠端醫療和遠端監控、飲食建議和治療後護理的數位健康工具的擴展，尿道結石管理變得更加全面，支持患者主動管理病情。隨著醫療保健系統繼續優先考慮以患者為中心的護理和先進的醫療技術，治療的創新、醫療意識的增強以及全球對改善泌尿系統結果的關注預計將推動對尿道結石管理設備的需求。

部分

治療類型（ESWL、腔內碎石術、經皮腎鏡碎石術、其他治療類型）；最終用途（醫院/診所、門診手術中心）

受訪公司範例（總合42家公司）

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP23002

Global Urolithiasis Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Urolithiasis Management Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Intracorporeal Lithotripsy Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 8.3% CAGR

The Urolithiasis Management Devices market in the U.S. is estimated at US$528.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.9 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Urolithiasis Management Devices Market - Key Trends & Drivers Summarized

What Are Urolithiasis Management Devices, and Why Are They So Crucial in Treating Kidney Stones?

Urolithiasis Management Devices are medical tools and equipment used to diagnose, manage, and treat urolithiasis, which is the formation of stones in the urinary system, including the kidneys, ureters, bladder, and urethra. Urolithiasis, commonly known as kidney stones, can cause severe pain, urinary blockages, and potential kidney damage if left untreated. These devices encompass a range of technologies, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents, which are designed to break down, remove, or facilitate the passage of kidney stones from the urinary tract. The devices allow for both non-invasive and minimally invasive treatment options, improving patient outcomes and reducing recovery times.

The importance of urolithiasis management devices lies in their ability to address a prevalent health condition that affects millions of individuals worldwide. Factors like dietary habits, dehydration, obesity, and certain medical conditions contribute to the development of kidney stones, making effective management crucial for maintaining renal health. Early diagnosis and timely treatment are essential to prevent complications such as infection, renal failure, and recurrent stone formation. Urolithiasis management devices provide healthcare professionals with tools to tailor treatment plans based on stone size, composition, and location, offering a patient-centric approach to kidney stone management. As the incidence of urolithiasis continues to rise globally, these devices play a critical role in ensuring effective, safe, and efficient treatment.

How Are Technological Advancements Shaping the Urolithiasis Management Devices Market?

Technological advancements have significantly enhanced the precision, efficacy, and safety of Urolithiasis Management Devices, driving innovation in kidney stone treatment. One of the most notable developments is the improvement in Extracorporeal Shock Wave Lithotripsy (ESWL), a non-invasive technique that uses focused shock waves to break kidney stones into smaller fragments that can be passed naturally. Modern ESWL devices are equipped with real-time imaging, improved stone localization, and patient positioning features, leading to higher success rates, reduced treatment times, and greater patient comfort. Additionally, advancements in electromagnetic and piezoelectric lithotripters have increased the precision and energy delivery of ESWL devices, enhancing stone fragmentation efficiency.

In minimally invasive procedures, ureteroscopes and nephroscopes have seen significant advancements in design, flexibility, and imaging capabilities. The development of digital ureteroscopes, which offer high-definition visualization, has improved the detection, targeting, and removal of stones in the urinary tract. Miniaturized and flexible ureteroscopes enable access to difficult-to-reach stones while minimizing trauma to surrounding tissues, reducing recovery times. Laser lithotripsy has also evolved, with innovations such as the use of holmium laser systems that offer high pulse rates, adjustable pulse widths, and dual-wavelength technology. These advancements allow for more efficient stone fragmentation, particularly in harder or larger stones, and provide better control over the procedure, enhancing safety.

Another key advancement is in the use of robotic-assisted surgical tools for complex cases of kidney stone removal. Robotic technologies offer greater precision, control, and dexterity, improving outcomes in percutaneous nephrolithotomy (PCNL) and other invasive procedures. Additionally, improved stent designs, such as drug-eluting and biodegradable stents, help in managing post-operative care, reducing complications like ureteral obstruction and infection. These technological innovations not only expand the capabilities of urolithiasis management devices but also align with broader trends toward minimally invasive, patient-friendly treatments that reduce hospital stays and healthcare costs.

What Are the Emerging Applications of Urolithiasis Management Devices Across Different Healthcare Settings?

Urolithiasis Management Devices are finding expanding applications across various healthcare settings, driven by the increasing prevalence of kidney stones and advancements in treatment modalities. In hospitals and specialized urology centers, these devices are widely used for both diagnostic and therapeutic purposes, supporting procedures like ESWL, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Urologists rely on advanced imaging and laser systems to ensure accurate stone localization, effective fragmentation, and complete removal, improving patient outcomes and reducing recurrence rates. These devices are also critical in outpatient surgical centers, where minimally invasive procedures are often performed to treat smaller stones, allowing for same-day discharge and faster recovery.

In emergency care settings, handheld ultrasound devices and portable imaging tools are becoming essential for rapid diagnosis and assessment of acute urolithiasis cases, enabling quick decision-making for appropriate treatment. Telemedicine platforms are also integrating diagnostic capabilities with remote consultation for initial assessment and follow-up care, supporting broader access to urolithiasis management. In primary care and clinics, non-invasive diagnostic tools like ultrasound and advanced urine analysis kits are used to detect stone formation early, facilitating timely referral to specialists and reducing the need for emergency interventions. Additionally, in-home care settings, wearable sensors and digital health apps are being used to monitor hydration, dietary intake, and potential stone symptoms, helping patients manage urolithiasis proactively. As healthcare becomes more decentralized and patient-centric, the applications of urolithiasis management devices are expanding, reflecting their versatility in addressing diverse healthcare needs across different care settings.

What Drives Growth in the Urolithiasis Management Devices Market?

The growth in the Urolithiasis Management Devices market is driven by several factors, including the rising prevalence of kidney stones, increasing adoption of minimally invasive treatments, and advancements in diagnostic and therapeutic technologies. One of the primary growth drivers is the global rise in urolithiasis cases, fueled by lifestyle factors such as poor hydration, high-sodium diets, obesity, and metabolic conditions like diabetes and hypertension. As the incidence of kidney stones increases, the demand for effective and timely management solutions has surged, making urolithiasis management devices essential tools for healthcare providers. The growing awareness of minimally invasive procedures, such as ESWL, ureteroscopy, and laser lithotripsy, has further driven the adoption of these devices, as patients and providers prefer treatments that offer faster recovery, reduced pain, and lower complication rates.

Advancements in imaging and laser technologies have also played a significant role in the market’s growth. The development of high-definition digital ureteroscopes, advanced lithotripters, and AI-driven diagnostic tools has improved the accuracy, safety, and efficiency of kidney stone treatment, leading to better patient outcomes. Additionally, the integration of AI and machine learning in imaging and diagnostics is enhancing stone detection, characterization, and treatment planning, making urolithiasis management more precise and personalized. Government initiatives and healthcare policies that promote better urological care, increased healthcare access, and awareness campaigns about kidney stone prevention and management have further supported market growth.

The rise of outpatient surgical centers and ambulatory care facilities has also contributed to the growth of the urolithiasis management devices market. These settings offer cost-effective and efficient treatments, increasing patient access to minimally invasive procedures. The expansion of telehealth and digital health tools for remote monitoring, dietary guidance, and post-treatment care has made urolithiasis management more comprehensive, supporting patients in managing their condition proactively. As healthcare systems continue to prioritize patient-centered care and advanced medical technologies, the demand for urolithiasis management devices is expected to grow, driven by innovations in treatment, increasing healthcare awareness, and the global focus on improving urological outcomes.

SCOPE OF STUDY:

The report analyzes the Urolithiasis Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types); End-Use (Hospitals & Clinics, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Urolithiasis Management Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Kidney Stones Drives Demand for Urolithiasis Management Devices
    • Growing Preference for Non-Surgical Treatments Sets the Stage for Device Adoption
    • Integration of Laser Technologies in Treatment Drives Urolithiasis Device Market
    • Expanding Role of Extracorporeal Shock Wave Lithotripsy (ESWL) Boosts Market Demand
    • Increasing Adoption of Ultrasound Imaging Drives Urolithiasis Treatment Solutions
    • Push for Single-Use Devices to Prevent Infections Boosts Device Adoption
    • Case Overview: Growth in Urology Clinics Enhances Demand for Urolithiasis Devices
    • Growing Use of Robotics in Stone Management Sets the Stage for Device Adoption
    • Focus on Outpatient Stone Treatment Enhances Market Opportunities
    • Increasing Prevalence of Obesity Propels Urolithiasis Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Intracorporeal Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Urolithiasis Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION